Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Adverse Event Reporting System Redesign Proposal Coming Soon

Executive Summary

FDA will publish a request-for-proposals to upgrade the agency's AERS safety database in the near future

You may also be interested in...



FDA Delays AERS Upgrade; New Maintenance Contract Goes To SAIC

FDA is working on approaches to obtain funding for a planned upgrade to the Adverse Event Reporting System

FDA Delays AERS Upgrade; New Maintenance Contract Goes To SAIC

FDA is working on approaches to obtain funding for a planned upgrade to the Adverse Event Reporting System

FDA Moves Ahead With Adverse Event Data-Mining; “White Paper” Out Soon

An FDA-PhRMA working group is finalizing a "white paper" on data mining as a tool in postmarketing safety surveillance

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel